The development of an integrated system for the management of pharmaceutical and surgical consumable products across a group of private hospitals : innovation report
- Publication date
- Publisher
Abstract
Continued pressure to reduce costs and manage healthcare delivery in risk-based reimbursement
environments, has, internationally, resulted in hospitals adopting different methods to manage
pharmaceutical and surgical consumable products. An initial review of systems of management of
these products showed that the trend is to manage them separately. Pharmaceutical products are
managed using dedicated resources and structures in each hospital, which may be difficult to
establish and sustain in smaller, non-academic hospitals. Amongst other factors, the absence of a
classification system and a lack of utilisation information hindered the development of management
systems for surgical consumable products. In addition, traditional materials management processes
applied to these products, often do not adequately address the impact that these products have on
clinical care. In this study, the decision was made to develop an integrated system for both
pharmaceutical and surgical consumable products and to adopt a systems approach in which all
hospitals in the group were included as a single system.
The study was multi-methodological with the design being contextual and qualitative and the
research strategy, exploratory and descriptive. A multi-phased, action research approach was used,
comprising of three (3) cycles, two (2) in which the integrated system was developed and enhanced
and a third in which it was independently tested in 19 newly acquired hospitals.
The result of the three (3) cycles was an implemented integrated system across 43 acute-care
hospitals in the group comprising six (6) processes namely: a product selection process,
information technology (IT) support system, a hospital implementation process, measurement and
management tools, pharmacy capability and a supplier strategy and interface process. These
processes included several key unique features, such as one (1) product selection team for all
hospitals, a surgical classification system based on functional therapeutic uses, a single IT system
and utilisation review capability for all products, extending the role of pharmacy departments in
hospitals to include the management of surgical consumable products and an integrated quality
assessment process for both types of products. By the end of the three (3) cycles (September
1999), the product selection process covered 66,5% of value of product spend, the percentage
reduction in the number of products used was 68% and the value of products purchased that
complied with specified products and suppliers was 90%. Ongoing and further application showed
that the integrated system could be sustained in existing hospitals, applied to a further four (4)
newly acquired hospitals and expanded to include specialised pharmaceutical and surgical
consumable products in cardiac catheterisation laboratories. By September 2003, the total spend
on pharmaceutical and surgical consumable products had reached R1,7 billion. The product
selection process covered 67,6% of total spend, the compliance value reached 95% and there were
additional financial improvements realised.
Following a further literature review, limitations and improvements to the approach were identified
and further adaptations were added as concepts in the graphic representation of system. One (1) of
these was to show the integrated system as an open system. The second adaptation highlighted
the systems-based input-process-outcomes feedback concept that is critical to continuous
improvement of the system. In the final progression, a systems approach to strategic planning and
management was incorporated in order to provide a structured approach for adapting to the rapid
and ongoing changes in healthcare and aligning the system of management of pharmaceutical and
surgical consumables to the overall business strategy.
Overall, this research study succeeded in bringing new perspectives and an innovative approach to
the management of pharmaceutical and surgical consumable products by developing and
implementing an integrated system for both products, establishing essential processes with key
unique features and tools, and the application of a systems thinking approach. Four (4) areas of
further research are suggested, namely testing the integrated system in other contexts, improved
methods of measurement of quality of care, extension to other areas of healthcare and use of the
systems approach in other areas of the business